194 related articles for article (PubMed ID: 38897821)
1. Combination Strategies and Targeted Radionuclide Therapies.
Jewell K; Kostos L; Emmerson B; Hofman MS
Semin Nucl Med; 2024 Jun; ():. PubMed ID: 38897821
[TBL] [Abstract][Full Text] [Related]
2. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
3. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications.
Sheehan B; Guo C; Neeb A; Paschalis A; Sandhu S; de Bono JS
Eur Urol Focus; 2022 Sep; 8(5):1157-1168. PubMed ID: 34167925
[TBL] [Abstract][Full Text] [Related]
5. Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.
Echavidre W; Fagret D; Faraggi M; Picco V; Montemagno C
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835533
[TBL] [Abstract][Full Text] [Related]
6. PSMA Theranostics: Current Landscape and Future Outlook.
Zhang H; Koumna S; Pouliot F; Beauregard JM; Kolinsky M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439177
[TBL] [Abstract][Full Text] [Related]
7. Requisites for successful theranostics with radionuclide-based reporter gene imaging.
Ahn BC
J Drug Target; 2014 May; 22(4):295-303. PubMed ID: 24417717
[TBL] [Abstract][Full Text] [Related]
8. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Burkett BJ; Bartlett DJ; McGarrah PW; Lewis AR; Johnson DR; Berberoğlu K; Pandey MK; Packard AT; Halfdanarson TR; Hruska CB; Johnson GB; Kendi AT
Radiol Imaging Cancer; 2023 Jul; 5(4):e220157. PubMed ID: 37477566
[TBL] [Abstract][Full Text] [Related]
9. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
[TBL] [Abstract][Full Text] [Related]
10. Radioligand therapies in meningioma - evidence and future directions.
Mair MJ; Tabouret E; Johnson DR; Sulman EP; Wen PY; Preusser M; Albert NL
Neuro Oncol; 2024 May; ():. PubMed ID: 38702966
[TBL] [Abstract][Full Text] [Related]
11. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Oprea-Lager DE; MacLennan S; Bjartell A; Briganti A; Burger IA; de Jong I; De Santis M; Eberlein U; Emmett L; Fizazi K; Gillessen S; Herrmann K; Heskamp S; Iagaru A; Jereczek-Fossa BA; Kunikowska J; Lam M; Nanni C; O'Sullivan JM; Panebianco V; Sala E; Sathekge M; Sosnowski R; Tilki D; Tombal B; Treglia G; Tunariu N; Walz J; Yakar D; Dierckx R; Sartor O; Fanti S
Eur Urol; 2024 Jan; 85(1):49-60. PubMed ID: 37743194
[TBL] [Abstract][Full Text] [Related]
12. Theranostic in Nuclear Medicine - The paradigm of NET.
Giammarile F
Hell J Nucl Med; 2023; 26 Suppl():42-43. PubMed ID: 37658562
[TBL] [Abstract][Full Text] [Related]
13. Theranostics in nuclear medicine practice.
Yordanova A; Eppard E; Kürpig S; Bundschuh RA; Schönberger S; Gonzalez-Carmona M; Feldmann G; Ahmadzadehfar H; Essler M
Onco Targets Ther; 2017; 10():4821-4828. PubMed ID: 29042793
[TBL] [Abstract][Full Text] [Related]
14. Current Status of Theranostics in Jordan.
Al-Ibraheem A; Mohamedkhair A
Nucl Med Mol Imaging; 2019 Feb; 53(1):7-10. PubMed ID: 30828393
[TBL] [Abstract][Full Text] [Related]
15. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases.
Dyer MR; Jing Z; Duncan K; Godbe J; Shokeen M
Nucl Med Biol; 2024; 130-131():108879. PubMed ID: 38340369
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in theranostics and challenges for the future.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20170893. PubMed ID: 29565650
[TBL] [Abstract][Full Text] [Related]
17. An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
[TBL] [Abstract][Full Text] [Related]
18. PSMA Theranostics: Science and Practice.
Mokoala K; Lawal I; Lengana T; Kgatle M; Giesel FL; Vorster M; Sathekge M
Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359805
[TBL] [Abstract][Full Text] [Related]
19. Theranostics in Oncology-Thriving, Now More than Ever.
Werner RA; Higuchi T; Pomper MG; Rowe SP
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33946670
[TBL] [Abstract][Full Text] [Related]
20. Theragnostic Radionuclide Pairs for Prostate Cancer Management:
Chhabra A; Thakur ML
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
